Med BioGene Inc.
TSX VENTURE : MBI

Med BioGene Inc.

April 29, 2011 08:30 ET

Med BioGene Announces New Address and Contact Particulars

VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 29, 2011) - Med BioGene Inc. (TSX VENTURE:MBI) today announced the following new address and contact particulars:

Med BioGene Inc.
701 West Georgia Street, Suite 1500
Vancouver, British Columbia V7Y 1C6
Phone: (800) 641-3593
Facsimile: (888) 646-2531

About Med BioGene

MBI is a life science company focused on the development and commercialization of genomic-based personalized clinical laboratory diagnostic tests. MBI is committed to advancing personalized medicine by commercializing tests that provide clinically relevant information to improve patient treatment and reduce health care costs. MBI and Precision Therapeutics have partnered to commercialize MBI's flagship test, LungExpress Dx. For more information on MBI, please visit www.medbiogene.com. For more information on Precision Therapeutics, please visit www.precisiontherapeutics.com.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information